GLP-1 CARE

GLP-1 Weight Loss Calculator for Women

See a personalized estimate of your weight loss timeline based on real clinical trial data, designed with women's bodies and life stages in mind.

Calculate weight loss

See what GLP-1s could mean for you

This calculator is for informational purposes only. Projections are derived from peer-reviewed Phase 3 clinical trials for each medication — see . Individual results vary.
1

Select your preferred medication

2

Your information

If yes, we'll factor in your current week rather than starting from zero.

Your results

Your personalized plan —

View as
    Estimates are based on clinical trial averages and are not medical advice. Life-stage factors are modeled directionally and may affect individual outcomes. Talk with a clinician before starting or changing any medication. Individual results are not guaranteed and may vary.
    1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989-1002. Read study →
    2. Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087. Read study →
    3. Wharton S, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Adults with Obesity (ATTAIN-1). N Engl J Med. 2025. Read study →
    4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. Read study →

    How this is calculated: each medication's timeline is modeled as a curve that reaches that trial's own reported mean body-weight loss (intention-to-treat / treatment-policy estimand) by that trial's own duration — 68 weeks for Wegovy injection (STEP 1), 64 weeks for Wegovy pill (OASIS 4), 72 weeks for Foundayo (ATTAIN-1, 36 mg dose), and 72 weeks for Zepbound (SURMOUNT-1) — then interpolated week by week. If you're already on the medication, the projection anchors to the current weight you entered rather than restarting the curve from zero, and models your remaining trajectory along the same curve shape. Life-stage adjustments shift the curve directionally based on general metabolic patterns; they are not values pulled from a specific trial subgroup. This tool does not model plateauing, dose-holding, or discontinuation, all of which affect real-world results.

    how it works

    How we built this calculator‍

    Get started
    01

    Grounded in real clinical trial data

    Projections are derived from peer-reviewed Phase 3 trials for Wegovy®, Zepbound®, and Foundayo™, which means they're based on real outcomes from real patients.

    02

    Built for women's biology

    Your life stage is factored in because hormonal shifts affect how GLP-1s work.

    03

    A starting point, not a care plan—yet

    Our projection is a data-informed estimate. Your clinician can help you build on it. They'll review your full history and turn it into an actual care plan.

    pricing

    What you'll pay

    Get started with GLP-1 Care
    glp-1 care membership
    $150
    $39
    / first month

    Then $150 /month

    • On-demand visits and messaging with metabolic and hormone health specialists
    • Two free specialist consultations (nutrition & strength training)
    • Dose adjustments and refills, when clinically appropriate
    • Side effect management
    • Personalized weight and metabolic insights
    • Pay-as-you-go access to Maven’s full provider network
    glp-1 medication
    From
    $149
    / month
    | for self-pay

    Varies by prescription and coverage

    • Self-pay options starting at $149/month for brand-name GLP-1s
    • As low as $25/month with insurance coverage
    • HSA/FSA eligible
    • Prescribed through Maven’s network of providers, filled and billed by your pharmacy
    faqs

    Your questions,

    answered

    GLP-1 receptor agonists are prescription medications that may help regulate appetite, blood sugar, and metabolism. For women, hormones, life stage, and muscle mass all play a role, so care should be designed with that full context in mind.

    Eligibility depends on factors like BMI, medical history, and existing conditions. We review your full health history—including conditions like PMOS/PCOS, perimenopause, or recent pregnancy—to determine whether treatment is appropriate. In some cases, we may require lab testing or prior medical records depending on your health history and location.

    Common side effects can include nausea, fatigue, constipation, or gastrointestinal discomfort. Hormonal shifts can also influence how women experience them, which is why we adjust dosing thoughtfully and proactively. GLP-1 medications can also carry serious risks, which your provider will review with you.

    Our clinicians specialize in women's metabolic and hormone health, which means they’re
    trained to consider how hormones, life stage, reproductive history, and biology all interact. That
    context shapes how we prescribe, monitor, and adjust your care.

    Most GLP-1 programs stop at the prescription. Maven integrates GLP-1 care into a broader women’s health model—combining clinical oversight, nutrition guidance, side effect and muscle-preserving support, and hormone-aware care across life stages.

    GLP-1 medications influence appetite and insulin sensitivity—both of which intersect with hormonal health. We consider menstrual changes, PCOS, perimenopause, and reproductive planning when guiding treatment.

    PMOS/PCOS is closely tied to insulin resistance, which GLP-1 medications directly address.
    By improving insulin sensitivity and moderating appetite signals, they can support blood sugar
    regulation and weight management—both of which affect PMOS/PCOS symptoms. For some
    women, this also leads to more regular menstrual cycles. GLP-1s aren't a standalone
    PMOS/PCOS treatment, but they can be a meaningful part of a broader care plan. We factor
    your PMOS/PCOS history into how we prescribe and monitor treatment.

    We prescribe only FDA-approved GLP-1 medications, including semaglutide (Wegovy®, Ozempic®), tirzepatide (Zepbound®), and orforglipron (Foundayo®). We don’t offer compounded formulations.

    Your monthly membership covers visits with your GLP-1 Care Team, dose adjustments, and two free specialist consultations for nutrition guidance and strength training support. GLP-1 medication costs are billed separately and may be covered by insurance. We help you understand potential coverage and self-pay options if needed.

    It depends on your plan. Many insurers cover GLP-1 medications for Type 2 diabetes; coverage
    for weight management is more variable. Before you start, we'll help you understand your
    benefits and explore potential coverage options. If your medication isn't covered, we'll walk
    through self-pay pricing and alternative options with you.

    Treatment duration is personal. Some women stay on GLP-1s long-term; others use them as a bridge to sustainable lifestyle changes. We help you develop a plan that makes sense for you.

    We build lifestyle habits and metabolic support into your care from day one—so if you decide to stop, you're set up to maintain your progress. Many people regain some weight after discontinuation, which is why we focus on sustainable, long-term health throughout your journey.

    Your care team includes prescribing clinicians who specialize in women’s metabolic and
    hormone health—available for visits and messaging throughout your care—along with a
    nutrition coach and a strength coach. Your first nutrition and strength consultations are
    included; you can book additional visits as your care evolves. Through Maven's virtual clinic,
    you can also connect with providers across 30+ specialties, including OB-GYNs, mental health
    providers, and reproductive health specialists.

    2
    Wegovy 0.25 mg semaglutide injection pen lying on a wooden surface.
    Smiling woman holding a baby wearing a diaper in a bright room.
    Woman with curly hair wearing a yellow and white patterned off-shoulder top, playing with a strand of her hair.
    Box of Wegovy 0.25 mg semaglutide injection containing 4 single-dose prefilled pens, displayed on a white surface with green leaves in the background.

    Get GLP-1 care that accounts for all of you

    Get started